Global standards for AI-designed proteins with community ownership
open
Global, Global
WS04685
AI-designed biological molecules may be created faster than their safety, ecological, and clinical properties can be characterized. The open problem is building evaluation pipelines proportionate to capability and deployment risk. Affected communities must have meaningful control over data, revenue, deployment decisions, and the right to refuse harmful applications. The research opportunity is to define measurable success criteria, test the approach in realistic settings, identify failure modes, and create a pathway from prototype to accountable deployment.